Renhe Liu - Publications

Affiliations: 
 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wang H, Xu M, Engelhart CA, Zhang X, Yan B, Pan M, Xu Y, Fan S, Liu R, Xu L, Hua L, Schnappinger D, Chen S. Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis. The Journal of Biological Chemistry. 296: 100257. PMID 33837735 DOI: 10.1016/j.jbc.2021.100257  0.659
2021 Wang H, Xu M, Engelhart CA, Zhang X, Yan B, Pan M, Xu Y, Fan S, Liu R, Xu L, Hua L, Schnappinger D, Chen S. Re-discovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in . The Journal of Biological Chemistry. PMID 33397709 DOI: 10.1074/jbc.RA120.016477  0.667
2019 Bakowski MA, Shiroodi RK, Liu R, Olejniczak J, Yang B, Gagaring K, Guo H, White PM, Chappell L, Debec A, Landmann F, Dubben B, Lenz F, Struever D, Ehrens A, et al. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. Science Translational Medicine. 11. PMID 31068442 DOI: 10.1126/Scitranslmed.Aav3523  0.66
2018 Gan F, Liu R, Wang F, Schultz PG. Functional replacement of histidine in proteins to generate noncanonical amino acid dependent organisms. Journal of the American Chemical Society. PMID 29509426 DOI: 10.1021/Jacs.7B13452  0.707
2016 Liu R, Wang RE, Wang F. Antibody-drug conjugates for non-oncological indications. Expert Opinion On Biological Therapy. PMID 26937991 DOI: 10.1517/14712598.2016.1161753  0.501
Show low-probability matches.